Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies

Overview of attention for article published in Frontiers in Pharmacology, December 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 13 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 6,231 followers.

RT @FrontPharmacol: New Research: Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-anal…

13 Dec 2022

Reply Repost Favourite

RT @FrontPharmacol: New Research: Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-anal…

13 Dec 2022

Reply Repost Favourite

RT @FrontPharmacol: New Research: Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-anal…

13 Dec 2022

Reply Repost Favourite

New Research: Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies https://t.co/vzgtCa1YAC #pharmacology

13 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.